Literature DB >> 22035809

Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study.

Gabriella Ferrandina1, Giovanna Mantegna, Marco Petrillo, Gilda Fuoco, Laura Venditti, Serena Terzano, Cristina Moruzzi, Domenica Lorusso, Andrea Marcellusi, Giovanni Scambia.   

Abstract

OBJECTIVES: This prospective, longitudinal study investigates QoL issues and emotional distress in early stage cervical cancer (ECC) patients undergoing radical surgery (RS) and in locally advanced cervical cancer (LACC) patients triaged to chemoradiation (CT/RT) followed by RS.
METHODS: The Global Health Status scale of EORTC QLQ-C30 (GHS), the EORTC QLQ-CX24 (CX24) and the Hospital Anxiety and Depression Scale (HADS) questionnaire were administered at baseline, and after 3, 6, and 12 months from surgery. For LACC patients QoL assessment was also performed after CT/RT. Statistical analysis was performed by the ANOVA for repeated measures and the Between Subject test.
RESULTS: In ECC and LACC patients, the GHS scores improved over time (5.5% difference in mean scores compared to baseline in ECC, and 7.0% difference in mean score compared to baseline in LACC patients). An early worsening of lymphedema scores was documented in ECC cases (14.6% difference in mean values compared to baseline, p value=0.001), and in LACC patients (difference up to 28.3% of mean values, value=0.0001). Menopausal symptoms persistently worsened over time reaching >15% difference of mean values compared to baseline in both groups. Sexual activity scores markedly improved both in ECC and LACC patients (difference of mean score values compared to baseline was 16.5% in ECC, and 6.7% in LACC patients). Both ECC and LACC patients experienced an improvement of anxiety scores.
CONCLUSIONS: Lymphedema and menopausal symptoms were the most disabling treatment-related sequelae; the amount of QoL issues and their multifaceted aspects require the cooperation of multidisciplinary teams.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22035809     DOI: 10.1016/j.ygyno.2011.09.041

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  32 in total

1.  A systematic review of the impact of contemporary treatment modalities for cervical cancer on women's self-reported health-related quality of life.

Authors:  L M Wiltink; M King; F Müller; M S Sousa; M Tang; A Pendlebury; J Pittman; N Roberts; L Mileshkin; R Mercieca-Bebber; M-A Tait; R Campbell; C Rutherford
Journal:  Support Care Cancer       Date:  2020-06-18       Impact factor: 3.603

2.  CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway.

Authors:  Juan Liu; Meng Wang; Xiaoli Zhang; Qingwei Wang; Mei Qi; Jing Hu; Zhiqiang Zhou; Chunyan Zhang; Weifang Zhang; Weiming Zhao; Xiao Wang
Journal:  Tumour Biol       Date:  2015-09-24

3.  Physical activity and lower limb lymphedema among uterine cancer survivors.

Authors:  Justin C Brown; Gabriella M John; Saya Segal; Christina S Chu; Kathryn H Schmitz
Journal:  Med Sci Sports Exerc       Date:  2013-11       Impact factor: 5.411

4.  Comparison of efficacy of meperidine and fentanyl in terms of pain management and quality of life in patients with cervical cancer receiving intracavitary brachytherapy: a double-blind, randomized controlled trial.

Authors:  Saengrawee Thanthong; Sirikorn Rojthamarat; Wipra Worasawate; Phongthara Vichitvejpaisal; Danupon Nantajit; Nantakarn Ieumwananontachai
Journal:  Support Care Cancer       Date:  2017-03-18       Impact factor: 3.603

5.  Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.

Authors:  Helen J Mackay; Lari Wenzel; Linda Mileshkin
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

6.  Physical activity, daily walking, and lower limb lymphedema associate with physical function among uterine cancer survivors.

Authors:  Justin C Brown; Lilie L Lin; Saya Segal; Christina S Chu; Ashley E Haggerty; Emily M Ko; Kathryn H Schmitz
Journal:  Support Care Cancer       Date:  2014-06-07       Impact factor: 3.603

7.  Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome.

Authors:  Lesley Stafford; Fiona Judd; Penny Gibson; Angela Komiti; G Bruce Mann; Michael Quinn
Journal:  Support Care Cancer       Date:  2015-01-06       Impact factor: 3.603

Review 8.  Cervical cancer survivorship: long-term quality of life and social support.

Authors:  Krista S Pfaendler; Lari Wenzel; Mindy B Mechanic; Kristine R Penner
Journal:  Clin Ther       Date:  2015-01-01       Impact factor: 3.393

9.  Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis.

Authors:  Shi-Yi Wang; Sylvia H Hsu; Cary P Gross; Tara Sanft; Amy J Davidoff; Xiaomei Ma; James B Yu
Journal:  Value Health       Date:  2016-04-07       Impact factor: 5.725

10.  Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse.

Authors:  Åsa H Everhov; Sara Ekberg; Angelica Lindén Hirschberg; Karin Bergmark; Angelique Flöter Rådestad; Ingrid Glimelius; Karin E Smedby
Journal:  J Cancer Surviv       Date:  2015-11-12       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.